Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Search Product Recalls

Try:····

Filters

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Showing 61–80 of 470 results

Sort:

Newest first Oldest first

Passionflower Herb Extract (Martin Bauer) – Misbranding (2025)

Misbranding of the ingredient the firm sells ( Passionflower Herb Extract )

Class IIModerate

FDAJul 22, 2025IN, NC• Martin Bauer, Inc.

BZK Antiseptic Towelette (Taizhou Kangping) – Sterility Issue (2025)

Lack of Assurance of Sterility.

Class IIModerate

FDAJul 22, 2025NY• Taizhou Kangping Medical Science And Technology Co., Ltd.

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 11.24 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide Niacinamide Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide + Cyanocobalamin Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide Niacinamide Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 8.8 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 13.2 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Semaglutide Cyanocobalamin Injection (Aequita) – Processing Controls (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Tirzepatide + Niacinamide 16.6 mg Injection (Aequita Pharmacy) – Processing Controls Issue (2025)

Lack of Processing Controls.

Class IIModerate

FDAJul 18, 2025MA• AEQUITA PHARMACY

Sushi Wasabi (Ming Hong) – Undeclared Yellow 5 (2025)

Individual consumer size Wasabi mini pack label does not declare allergen ingredient Yellow 5.

Class IIModerate

FDAJul 16, 2025CA, CO, FL +17 more• MING HONG INTERNATIONAL INC.

Power Stick Roll-On Antiperspirant (A.P. Deauville) – Quality Control Issue (2025)

CGMP Deviations

Class IIModerate

FDAJul 10, 2025Nationwide• A.P. Deauville, LLC

Shave Power Stick Deodorant (A.P. Deauville) – Quality Control Issue (2025)

CGMP Deviations

Class IIModerate

FDAJul 10, 2025Nationwide• A.P. Deauville, LLC

Beauty Power Stick Deodorant (A.P. Deauville) – Quality Control Issue (2025)

CGMP Deviations

Class IIModerate

FDAJul 10, 2025Nationwide• A.P. Deauville, LLC

Semaglutide Injection (Boothwyn Pharmacy) – Subpotent Drug (2025)

Subpotent Drug

Class IIModerate

FDAJul 9, 2025Nationwide• Boothwyn Pharmacy LLC

1 2 345 6...24

Page 4 of 24Next